Joshua Brown, Pharm.D., Ph.D., M.S.
Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 294-8593
Business Email:
joshua.brown@cop.ufl.edu
About Joshua Brown
Joshua Brown joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2016. He has experience in clinical pharmacy, health economics and outcomes research, and pharmacoepidemiology across academic, pharmaceutical industry, and managed care. His current research program and collaborations focus on research methods for pharmacoepidemiologic and pharmacoeconomic generic and biosimilar evaluations, developing real-world evidence for drug-drug interactions, and conducting translational research in aging and aging-related diseases. His academic work has been funded by the NIH, FDA, Bill & Melinda Gates Foundation, and the PhRMA Foundation.
Joshua has published over 120 papers and holds several editorial positions with high impact specialty journals in pharmacy and cardiovascular diseases and is actively involved in AMCP, ISPE, and ISPOR scientific societies. Dr. Brown was awarded as the AMCP Foundation’s “New Practitioner” for his early career contributions to managed care pharmacy. Dr. Brown is the faculty advisor of UF’s AMCP student chapter and has mentored over 20 graduate and pharmacy students in research.
Accomplishments
NIH Loan Repayment Program Award
2020-2022
·
NIH-National Institute on Aging
Emerging Leader
2019
·
National Academy of Medicine
New Practitioner Award
2019
·
Academy of Managed Care Pharmacy
NIH Loan Repayment Program Award
2018-2020
·
NIH – National Institute on Aging
Claude D. Pepper Junior Scholar
2017-2019
·
UF Institute on Aging
Publications
2021
A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug-drug Interactions.
Epidemiology (Cambridge, Mass.).
32(2):268-276
[DOI] 10.1097/EDE.0000000000001302.
[PMID] 33196560.
2021
Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis
Journal of Managed Care \& Specialty Pharmacy.
27(6)
2021
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system
Contraception.
103(4)
2021
Differences in Health-Related Quality of Life Among Adults with a Potential Dihydropyridine Calcium Channel Blocker–Loop Diuretic Prescribing Cascade
Drugs \& Aging.
2021
Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation
Medical Cannabis and Cannabinoids.
2021
Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit
Medical Cannabis and Cannabinoids.
2021
Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study
Medicine.
100(1)
2021
Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines
Clinical and Translational Science.
2021
Perinatal Cannabis Exposures and Autism Spectrum Disorders
Medical Cannabis and Cannabinoids.
4(1)
2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilate
CPT: pharmacometrics \& systems pharmacology.
10(3)
2021
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment.
Clinical pharmacology and therapeutics.
109(1):193-200
[DOI] 10.1002/cpt.2087.
[PMID] 33073366.
2021
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Research in social & administrative pharmacy : RSAP.
17(2):483-486
[DOI] 10.1016/j.sapharm.2020.04.016.
[PMID] 32327397.
2021
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic.
Research in social & administrative pharmacy : RSAP.
17(8):1478-1482
[DOI] 10.1016/j.sapharm.2020.11.005.
[PMID] 33221267.
2021
The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia
Journal of Managed Care \& Specialty Pharmacy.
27(5)
2021
Three-Year, Postintervention, Follow-up Comparison of Health Care Resource Utilization and Costs in the Lifestyle Interventions and Independence for Elders (LIFE) Study.
The journals of gerontology. Series A, Biological sciences and medical sciences.
76(2):272-276
[DOI] 10.1093/gerona/glaa088.
[PMID] 32270182.
2021
Utilization patterns of skeletal muscle relaxants among commercially insured adults in the United States from 2006 to 2018
Pain Medicine.
2020
A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA’s Sentinel Initiative
Journal of Managed Care \& Specialty Pharmacy.
26(8)
2020
Antihypertensive drugs and risk of COVID-19?
The Lancet Respiratory Medicine.
8(5)
2020
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
Journal of managed care & specialty pharmacy.
26(3):268-274
[DOI] 10.18553/jmcp.2020.26.3.268.
[PMID] 32105168.
2020
Association between a Deficit Accumulation Frailty Index and Mobility Outcomes in Older Adults: Secondary Analysis of the Lifestyle Interventions and Independence for Elders (LIFE) Study.
Journal of clinical medicine.
9(11)
[DOI] 10.3390/jcm9113757.
[PMID] 33266358.
2020
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.
JAMA network open.
3(4)
[DOI] 10.1001/jamanetworkopen.2020.3593.
[PMID] 32329770.
2020
Atopic Disease and Anemia in Korean Patients: Cross-Sectional Study with Propensity Score Analysis.
International journal of environmental research and public health.
17(6)
[DOI] 10.3390/ijerph17061978.
[PMID] 32197291.
2020
Breaking the rules for studies using real-world observational data: the case of direct-acting anticoagulants and antiepileptic drugs
European Heart Journal-Cardiovascular Pharmacotherapy.
6(3)
2020
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic.
Research in social \& administrative pharmacy: RSAP.
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry.
Journal of clinical medicine.
9(4)
[DOI] 10.3390/jcm9041166.
[PMID] 32325769.
2020
Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Response to a Physical Activity Intervention in Older Adults: Results From the Lifestyle Interventions and Independence for Elders Study.
The journals of gerontology. Series A, Biological sciences and medical sciences.
75(5):1010-1016
[DOI] 10.1093/gerona/glz120.
[PMID] 31070702.
2020
Effect of enzyme-inducing antiepileptic drugs on failure of oral low-dose hormonal contraceptives
.
29
2020
Healthcare Utilization and Physical Functioning in Older Adults in the United States.
Journal of the American Geriatrics Society.
68(2):266-271
[DOI] 10.1111/jgs.16260.
[PMID] 31755551.
2020
Higher insulin expenditures associated with utilization of free medication samples.
Research in social & administrative pharmacy : RSAP.
16(9):1302-1305
[DOI] 10.1016/j.sapharm.2019.04.001.
[PMID] 31027965.
2020
Impact of Anticholinergic Medication Burden on Mobility and Falls in the Lifestyle Interventions for Elders (LIFE) Study.
Journal of clinical medicine.
9(9)
[DOI] 10.3390/jcm9092989.
[PMID] 32947839.
2020
Impact of hepatitis C virus treatment on the risk of non-hepatic cancers among hepatitis C virus-infected patients in the US
Alimentary pharmacology \& therapeutics.
52(10)
2020
Impact of opioid dose escalation on pain intensity: a retrospective cohort study
Pain.
161(5)
2020
Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study
Addiction.
115(6)
2020
Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients
.
8(4)
2020
Machine Learning in Drug Discovery and Development Part 1: A Primer.
CPT: pharmacometrics & systems pharmacology.
9(3):129-142
[DOI] 10.1002/psp4.12491.
[PMID] 31905263.
2020
Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States.
Journal of infection and public health.
13(1):101-103
[DOI] 10.1016/j.jiph.2019.06.010.
[PMID] 31279802.
2020
OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome.
Research in social & administrative pharmacy : RSAP.
16(12):1789-1791
[DOI] 10.1016/j.sapharm.2020.03.010.
[PMID] 32265114.
2020
Perception of prescription drug monitoring programs as a prevention tool in primary medical care.
Research in social & administrative pharmacy : RSAP.
16(9):1306-1308
[DOI] 10.1016/j.sapharm.2019.03.012.
[PMID] 30935769.
2020
Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions.
Journal of clinical medicine.
9(4)
[DOI] 10.3390/jcm9040919.
[PMID] 32230864.
2020
Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States
Clinical and translational science.
13(2)
2020
Readmissions after Pancreatic Surgery in Patients with Pancreatic Cancer: Does Hospital Variation Exist for Quality Measurement?
Visceral Medicine.
36(4)
2020
Reliability and Validity of the Short-Form 12 Item Version 2 (SF-12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population.
Journal of clinical medicine.
9(3)
[DOI] 10.3390/jcm9030661.
[PMID] 32121371.
2020
Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study.
Clinical pharmacology and therapeutics.
108(1):81-89
[DOI] 10.1002/cpt.1807.
[PMID] 32022906.
2020
Risks of acute gastrointestinal adverse events associated with metastatic melanoma therapies: A retrospective cohort study
.
29
2020
Trajectories of Short Physical Performance Battery Are Strongly Associated with Future Major Mobility Disability: Results from the LIFE Study.
Journal of clinical medicine.
9(8)
[DOI] 10.3390/jcm9082332.
[PMID] 32707877.
2020
Updating the Cost Effectiveness of Oral Anticoagulants for Patients with Atrial Fibrillation Based on Varying Stroke and Bleed Risk Profiles.
PharmacoEconomics.
38(12):1333-1343
[DOI] 10.1007/s40273-020-00960-0.
[PMID] 32924092.
2020
What Do You Meme, Professor? An Experiment Using “Memes” in Pharmacy Education.
Pharmacy (Basel, Switzerland).
8(4)
[DOI] 10.3390/pharmacy8040202.
[PMID] 33138086.
2019
Association of Adverse Drug Events with Hospitalization Outcomes and Costs in Older Adults in the USA using the Nationwide Readmissions Database.
Pharmaceutical medicine.
33(4):321-329
[DOI] 10.1007/s40290-019-00286-z.
[PMID] 31933184.
2019
Can apixaban prevent venous thromboembolism better than rivaroxaban?–Authors’ reply
The Lancet Haematology.
6(4)
2019
Central Nervous System Effects of Oral Propranolol for Infantile Hemangioma: A Systematic Review and Meta-Analysis.
Journal of clinical medicine.
8(2)
[DOI] 10.3390/jcm8020268.
[PMID] 30813242.
2019
Commentary on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.
Annals of medicine.
51(1):97-98
[DOI] 10.1080/07853890.2019.1581941.
[PMID] 30801227.
2019
Comparative effects of ACE inhibitors and ARBs on response to a physical activity intervention in older adults: results from lifestyle interventions for elders (LIFE) study
J Gerontol A Biol Sci Med Sci.
2019
Critique of” Risk of Gynecomastia with Users of Proton Pump Inhibitors”.
Pharmacotherapy.
39(7)
2019
Disparities in the Use of Cardiac Rehabilitation after a Myocardial Infarction in the United States.
Journal of clinical medicine.
8(7)
[DOI] 10.3390/jcm8071006.
[PMID] 31295853.
2019
Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (LIFE) Study.
Pharmacotherapy.
39(8):816-826
[DOI] 10.1002/phar.2299.
[PMID] 31230397.
2019
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
The Lancet Haematology.
6(1)
2019
Evaluating the clinical impact of formulation variability: a metoprolol extended-release case study
The Journal of Clinical Pharmacology.
59(9)
2019
Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis.
Drug and alcohol dependence.
202:172-177
[DOI] 10.1016/j.drugalcdep.2019.05.025.
[PMID] 31352307.
2019
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Database.
2019
2019
Letter to the editor: The prevalence of drivers under the influence of medical cannabis must be considered within proper context
Research in social and administrative pharmacy.
2019
Patients’ reasons for weight loss and their relations to clinical weight loss outcomes in a comprehensive lifestyle intervention
Obesity science \& practice.
5(6)
2019
Perception of Prescription Drug Monitoring Program Effectiveness in Primary Care: Evidence from Three States
.
2019
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology-What’s Next?-Joining Mechanistic and Epidemiological Approaches.
CPT: pharmacometrics & systems pharmacology.
8(6):352-355
[DOI] 10.1002/psp4.12425.
[PMID] 31179639.
2019
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.
Journal of clinical medicine.
8(7)
[DOI] 10.3390/jcm8070989.
[PMID] 31288397.
2019
Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States
medRxiv.
2019
Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
BMC cardiovascular disorders.
19(1)
[DOI] 10.1186/s12872-019-1033-3.
[PMID] 30890131.
2019
Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case Study.
Journal of clinical pharmacology.
59(9):1275-1284
[DOI] 10.1002/jcph.1436.
[PMID] 31087552.
2019
Risk Factors Associated With 7- Versus 30-Day Readmission Among Patients With Heart Failure Using the Nationwide Readmission Database.
Medical care.
57(1):1-7
[DOI] 10.1097/MLR.0000000000001006.
[PMID] 30363021.
2019
Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016.
Journal of clinical medicine.
9(1)
[DOI] 10.3390/jcm9010083.
[PMID] 31905718.
2018
A review of interventions to increase vena cava filter retrieval rates
Annals of vascular surgery.
51
2018
Establishing a multidisciplinary framework to study drug-drug interactions of hormonal contraceptives: an invitation to collaborate
CPT: pharmacometrics \& systems pharmacology.
7(11)
2018
Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood?
Research in social \& administrative pharmacy: RSAP.
14(6)
2018
Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care
Vascular Medicine.
23(4)
2018
Mass casualty shooting venues, types of firearms, and age of perpetrators in the United States, 1982–2018
American journal of public health.
108(10)
2018
Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US-A Cross-Sectional Analysis
Value in Health.
21
2018
Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinic
Patient safety in surgery.
12(1)
2018
Payer and pharmaceutical manufacturer considerations for outcomes-based agreements in the United States
Value in Health.
21(1)
2018
Real-world adherence to warfarin, dabigatran, rivaroxaban, and apixaban among patient with nonvalvular atrial fibrillation: 2010-2015
.
27
2018
Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly
Value in Health.
21
2018
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Journal of the American Heart Association.
7(6)
[DOI] 10.1161/JAHA.117.007901.
[PMID] 29514808.
2018
Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment
The Journal of rural health.
34(1)
2018
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment
Journal of Thrombosis and Haemostasis.
16(12)
2018
The need for deliberate and thorough design and critique of observational comparative effectiveness research.
Research in Social \& Administrative Pharmacy.
14(11)
2018
The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States
BMC geriatrics.
18(1)
2018
Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort
Journal of Vascular Surgery: Venous and Lymphatic Disorders.
6(1)
2017
Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 data
Journal of managed care \& specialty pharmacy.
23(9)
2017
Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures
Pharmacy.
5(1)
2017
Epidemiologic analysis along the mevalonate pathway reveals improved cancer survival in patients who receive statins alone and in combination with bisphosphonates
JCO clinical cancer informatics.
1
2017
Hospital variation and patient characteristics associated with vena cava filter utilization
Medical care.
55(1)
2017
Immune checkpoint inhibition and the prevalence of autoimmune disorders among patients with lung and renal cancer
Cancer informatics.
16
2017
Is midazolam a constitutional or pharmacological alternative in lethal injections?
Research in Social \& Administrative Pharmacy.
14(1)
2017
Opioid Drug Exposures and Health Care Utilization Measures Associated with Neonatal Abstinence Syndrome in Florida, 2011-2015
J Gynec Obstet.
1
2017
Statin use and venous thromboembolism in cancer: a large, active comparator, propensity score matched cohort study
Thrombosis research.
158
2017
The Power and Pitfalls of Big Data Research in Obstetrics and Gynecology: A Consumer’s Guide.
Obstetrical & gynecological survey.
72(11):669-682
[DOI] 10.1097/OGX.0000000000000504.
[PMID] 29164265.
2017
Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence Syndrome—Reply
JAMA pediatrics.
171(7)
2017
Utilization of free medication samples in the United States in a nationally representative sample: 2009–2013
Research in Social and Administrative Pharmacy.
13(1)
2017
Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort
Journal of the American Heart Association.
6(9)
2016
A comparison of oral anticoagulant use for atrial fibrillation in the pre-and post-DOAC eras
Drugs \& aging.
33(6)
2016
Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillation
Journal of managed care \& specialty pharmacy.
22(11)
2016
Anticoagulation treatment for stroke prevention in atrial fibrillation is increasing, but further improvements needed
Journal of the American College of Cardiology.
68(22)
2016
Impact of time-varying treatment exposures on the risk of venous thromboembolism in multiple myeloma
.
4(4)
2016
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma.
Healthcare (Basel, Switzerland).
4(4)
[DOI] 10.3390/healthcare4040093.
[PMID] 27999418.
2016
Low-cost generic program use by Medicare beneficiaries: implications for medication exposure misclassification in administrative claims data
Journal of managed care \& specialty pharmacy.
22(6)
2016
Rates of neonatal abstinence syndrome amid efforts to combat the opioid abuse epidemic
JAMA pediatrics.
170(11)
2016
Variation in the use of vena cava filters for venous thromboembolism in hospitals in Kentucky
JAMA surgery.
151(10)
Grants
Sep 2020
ACTIVE
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Oct 2019
ACTIVE
Quality of care for inferior vena cava filters at UF Health Shands Hospital
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Jul 2019
– Dec 2020
Consortium for Medical Marijuana Clinical Outcomes Research
Role: Project Manager
Funding: STATE UNIVERSITY SYSTEM OF FLORIDA
via FL LEGISLATURE
Nov 2017
ACTIVE
Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications
Role: Co-Investigator
Funding: GATES FOU, BILL & MELINDA
Sep 2017
– Feb 2019
Comparative effectiveness of direct-acting oral anticoagulants (DOACs) for stroke prevention in atrial fibrillation: Influence of study methods on the usefulness of the results in the real-world
Role: Principal Investigator
Funding: PHARMA RES AND MANUFACTURERS OF AMERICA
Sep 2014
– Aug 2018
A Model- and Systems-based Approach to Efficacy and Safety Questions Related to Generic Substitution
Role: Co-Investigator
Funding: US FOOD AND DRUG ADMN
Education
Ph.D.
2016
·
University of Kentucky
M.S.
2014
·
University of Arkansas for Medical Science
Pharm.D.
2014
·
University of Arkansas for Medical Science
B.S.
2010
·
University of Arkansas
Teaching Profile
Courses Taught
2017-2020
PHA5223 P-Epidem Drug Safety
2017-2018,2020-2021
PHA7980 Research for Doctoral Dissertation
2017-2018,2020-2021
PHA6910 Supervised Research
2020
PHA6805 Applied Data Interpretation and Reporting of Findings in Pharmacy
2017-2018,2020-2021
PHA7979 Advanced Research
2017,2020-2021
PHA6935 Selected Topics in Pharmacy
2018-2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2019-2021
PHA6940 Supervised Teaching
2017-2018,2020-2021
PHA6971 Research for Master’s Thesis
2017,2019-2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2017-2021
PHA6937 Topics in Pharmaceutical Administration
2017-2018
PHA5788C Patient Care 6
2018,2021
PHA5166L Prof Skills Lab Vi
2017
PHA6266 Introduction to Pharmaceutical Outcomes and Policy II
2021
PHA5956 Special Topics/Self-Directed Study
2021
PHA6894 Introduction to Graduate Studies
Contact Details
Phones:
- Business:
- (352) 294-8593
Emails:
- Business:
- joshua.brown@cop.ufl.edu